Locoregional radionuclide therapy of glioblastoma with [211At]At-PDA-FAPI

Locoregional radionuclide therapy of glioblastoma with [211At]At-PDA-FAPI

Abstract Glioblastoma is the most common and aggressive tumor of the central nervous system. Locoregional administration of therapeutic radiopharmaceuticals appears to be a promising modality for recurrent glioblastomas. In this study, fibroblast activation protein alpha (FAPα) targeting molecule fi...

Full description

Saved in:
Bibliographic Details
Main Authors: Huan Ma, Tianzhen Ye, Guofeng Qu, Yilin Qin, Jiali Liao, Yuanyou Yang, Wei Zhang, Ning Liu, Feize Li
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Scientific Reports
Subjects:
Astatine-211
Targeted alpha therapy
Fibroblast activation protein inhibitor
Glioblastoma
Polydopamine
Online Access:https://doi.org/10.1038/s41598-025-03356-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-03356-2

Similar Items